vs

Side-by-side financial comparison of CITIZENS FINANCIAL SERVICES INC (CZFS) and PRECISION BIOSCIENCES INC (DTIL). Click either name above to swap in a different company.

PRECISION BIOSCIENCES INC is the larger business by last-quarter revenue ($34.2M vs $29.6M, roughly 1.2× CITIZENS FINANCIAL SERVICES INC). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs 35.4%, a 23.5% gap on every dollar of revenue. On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs 13.0%). CITIZENS FINANCIAL SERVICES INC produced more free cash flow last quarter ($35.2M vs $-11.3M). Over the past eight quarters, PRECISION BIOSCIENCES INC's revenue compounded faster (39.5% CAGR vs 6.9%).

Citizens Financial Group, Inc. is an American bank holding company, headquartered in Providence, Rhode Island. The company owns the bank Citizens Bank, N.A., which operates in the U.S. states of Connecticut, Delaware, Florida, Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, Vermont, and Virginia, as well as Washington, DC.

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

CZFS vs DTIL — Head-to-Head

Bigger by revenue
DTIL
DTIL
1.2× larger
DTIL
$34.2M
$29.6M
CZFS
Growing faster (revenue YoY)
DTIL
DTIL
+5248.2% gap
DTIL
5261.1%
13.0%
CZFS
Higher net margin
DTIL
DTIL
23.5% more per $
DTIL
58.9%
35.4%
CZFS
More free cash flow
CZFS
CZFS
$46.5M more FCF
CZFS
$35.2M
$-11.3M
DTIL
Faster 2-yr revenue CAGR
DTIL
DTIL
Annualised
DTIL
39.5%
6.9%
CZFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CZFS
CZFS
DTIL
DTIL
Revenue
$29.6M
$34.2M
Net Profit
$10.5M
$20.1M
Gross Margin
Operating Margin
44.2%
36.6%
Net Margin
35.4%
58.9%
Revenue YoY
13.0%
5261.1%
Net Profit YoY
31.3%
213.5%
EPS (diluted)
$2.17
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CZFS
CZFS
DTIL
DTIL
Q4 25
$29.6M
$34.2M
Q3 25
$29.0M
$13.0K
Q2 25
$27.3M
$18.0K
Q1 25
$26.4M
$29.0K
Q4 24
$26.2M
$638.0K
Q3 24
$25.1M
$576.0K
Q2 24
$24.6M
$49.9M
Q1 24
$25.9M
$17.6M
Net Profit
CZFS
CZFS
DTIL
DTIL
Q4 25
$10.5M
$20.1M
Q3 25
$10.0M
$-21.8M
Q2 25
$8.5M
$-23.5M
Q1 25
$7.6M
$-20.6M
Q4 24
$8.0M
Q3 24
$7.5M
$-16.4M
Q2 24
$5.3M
$32.7M
Q1 24
$7.0M
$8.6M
Operating Margin
CZFS
CZFS
DTIL
DTIL
Q4 25
44.2%
36.6%
Q3 25
42.6%
-158976.9%
Q2 25
38.1%
-121538.9%
Q1 25
35.5%
-76248.3%
Q4 24
37.2%
Q3 24
36.9%
-3693.6%
Q2 24
25.9%
48.4%
Q1 24
32.8%
-23.8%
Net Margin
CZFS
CZFS
DTIL
DTIL
Q4 25
35.4%
58.9%
Q3 25
34.5%
-167476.9%
Q2 25
31.0%
-130666.7%
Q1 25
28.8%
-70913.8%
Q4 24
30.5%
Q3 24
30.0%
-2851.6%
Q2 24
21.4%
65.6%
Q1 24
27.1%
48.8%
EPS (diluted)
CZFS
CZFS
DTIL
DTIL
Q4 25
$2.17
$2.62
Q3 25
$2.09
$-1.84
Q2 25
$1.76
$-2.13
Q1 25
$1.60
$-2.21
Q4 24
$1.64
Q3 24
$1.57
$-2.25
Q2 24
$1.10
$4.67
Q1 24
$1.48
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CZFS
CZFS
DTIL
DTIL
Cash + ST InvestmentsLiquidity on hand
$34.3M
$115.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$338.1M
$92.2M
Total Assets
$3.1B
$154.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CZFS
CZFS
DTIL
DTIL
Q4 25
$34.3M
$115.6M
Q3 25
$31.1M
$44.9M
Q2 25
$49.5M
$62.2M
Q1 25
$36.8M
$77.2M
Q4 24
$42.2M
$86.3M
Q3 24
$36.8M
$101.2M
Q2 24
$38.4M
$123.6M
Q1 24
$29.6M
$137.8M
Stockholders' Equity
CZFS
CZFS
DTIL
DTIL
Q4 25
$338.1M
$92.2M
Q3 25
$327.7M
$16.6M
Q2 25
$313.7M
$34.1M
Q1 25
$308.3M
$49.3M
Q4 24
$299.7M
$56.4M
Q3 24
$298.7M
$64.9M
Q2 24
$286.5M
$74.7M
Q1 24
$282.7M
$37.2M
Total Assets
CZFS
CZFS
DTIL
DTIL
Q4 25
$3.1B
$154.4M
Q3 25
$3.1B
$93.5M
Q2 25
$3.0B
$108.9M
Q1 25
$3.0B
$124.4M
Q4 24
$3.0B
$136.4M
Q3 24
$3.0B
$153.3M
Q2 24
$2.9B
$165.8M
Q1 24
$2.9B
$184.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CZFS
CZFS
DTIL
DTIL
Operating Cash FlowLast quarter
$36.5M
$-11.3M
Free Cash FlowOCF − Capex
$35.2M
$-11.3M
FCF MarginFCF / Revenue
119.0%
-32.9%
Capex IntensityCapex / Revenue
4.4%
0.1%
Cash ConversionOCF / Net Profit
3.49×
-0.56×
TTM Free Cash FlowTrailing 4 quarters
$53.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CZFS
CZFS
DTIL
DTIL
Q4 25
$36.5M
$-11.3M
Q3 25
$2.9M
$-15.3M
Q2 25
$6.0M
$-20.3M
Q1 25
$10.9M
$-19.1M
Q4 24
$33.2M
$-58.4M
Q3 24
$6.2M
$-5.9M
Q2 24
$3.0M
$-14.9M
Q1 24
$13.5M
$-19.0M
Free Cash Flow
CZFS
CZFS
DTIL
DTIL
Q4 25
$35.2M
$-11.3M
Q3 25
$2.7M
Q2 25
$5.5M
$-20.3M
Q1 25
$10.4M
$-19.1M
Q4 24
$31.9M
$-58.7M
Q3 24
$5.6M
$-6.0M
Q2 24
$2.9M
$-14.9M
Q1 24
$13.4M
$-19.1M
FCF Margin
CZFS
CZFS
DTIL
DTIL
Q4 25
119.0%
-32.9%
Q3 25
9.4%
Q2 25
20.1%
-112627.8%
Q1 25
39.2%
-65917.2%
Q4 24
121.6%
-9199.8%
Q3 24
22.3%
-1033.2%
Q2 24
11.8%
-29.9%
Q1 24
51.5%
-108.4%
Capex Intensity
CZFS
CZFS
DTIL
DTIL
Q4 25
4.4%
0.1%
Q3 25
0.5%
0.0%
Q2 25
1.8%
11.1%
Q1 25
2.2%
220.7%
Q4 24
5.0%
39.2%
Q3 24
2.5%
6.8%
Q2 24
0.5%
0.1%
Q1 24
0.4%
0.5%
Cash Conversion
CZFS
CZFS
DTIL
DTIL
Q4 25
3.49×
-0.56×
Q3 25
0.29×
Q2 25
0.71×
Q1 25
1.44×
Q4 24
4.16×
Q3 24
0.83×
Q2 24
0.57×
-0.45×
Q1 24
1.92×
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons